Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Acadia Healthcare Company, Inc.ACHC · Entity 4312 | Director | May 06, 2026 | May 08, 2026 |
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director | July 22, 2026 | July 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Acadia Healthcare Company, Inc.
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,628 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 6,331 · Balance 42,628 F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027.
QUEST DIAGNOSTICS INC
Report date July 22, 2026 · Filed July 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 18,386 |
Reported balance
After 2026-07-22 transaction · row 1
1 source rowRow 1 · 2026-07-22 · Grant · Acquired 72 · Balance 18,386 F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
TEAM HEALTH HOLDINGS INC.
Report date February 06, 2017 · Filed February 08, 2017
Section 16 reporting ended · disclosed 2017-02-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 1
1 source rowRow 1 · 2017-02-06 · Disposition to issuer · Disposed 6,498 · Balance 0 F1: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable witholding taxes. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-02-06 · Disposition to issuer · Disposed 916 · Balance 0 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F4: These restricted stock units were to vest on May 20, 2017. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2017-02-06 · Disposition to issuer · Disposed 1,630 · Balance 0 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F5: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the May 21, 2015 grant date. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-02-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-02-06 · Disposition to issuer · Disposed 3,320 · Balance 0 F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F6: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable witholding taxes.
F2: Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F3: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person.
F4: These restricted stock units were to vest on May 20, 2017.
F5: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the May 21, 2015 grant date.
F6: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 22, 2026 Filed Jul 27, 2026 20:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 72 | $206.81 | $14,890.18 |
DisclosureSEC source: 0001022079-26-000084 · wk-form4_1785184496.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,386 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| May 20, 2026 Filed May 21, 2026 20:58 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001510304-26-000005 · wk-form4_1779397113.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,314 F1 · security: Represents an award of restricted stock units. Read SEC document |
| May 06, 2026 Filed May 8, 2026 21:01 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 6,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-214931 · ownership.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,628 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 6, 2027. Read SEC document |
| April 20, 2026 Filed Apr 24, 2026 22:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 68 | $194.70 | $13,239.46 |
DisclosureSEC source: 0001022079-26-000048 · wk-form4_1777069449.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,172 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| January 28, 2026 Filed Feb 20, 2026 22:06 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 67 | $183.51 | $12,295.37 |
DisclosureSEC source: 0001510304-26-000002 · wk-form4_1771625188.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,104 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| November 25, 2025 Filed Nov 28, 2025 21:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,250 | $191.76 | $239,700.00 |
DisclosureSEC source: 0001022079-25-000232 · wk-form4_1764365428.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,037 Read SEC document |
| October 21, 2025 Filed Oct 24, 2025 22:10 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 70 | $189.08 | $13,235.74 |
DisclosureSEC source: 0001022079-25-000226 · wk-form4_1761343805.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,287 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| July 21, 2025 Filed Jul 25, 2025 20:26 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 79 | $167.50 | $13,232.11 |
DisclosureSEC source: 0001022079-25-000185 · wk-form4_1753475203.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,217 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| May 29, 2025 Filed May 30, 2025 21:11 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 7,032 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-079850 · ownership.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,297 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 29, 2026. Read SEC document |
| May 15, 2025 Filed May 19, 2025 20:23 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,203 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-25-000148 · wk-form4_1747686206.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,138 F1 · security: Represents an award of restricted stock units. Read SEC document |
| April 21, 2025 Filed May 2, 2025 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 68 | $164.42 | $11,180.70 |
DisclosureSEC source: 0001022079-25-000127 · wk-form4_1746217881.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,935 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| February 05, 2025 Filed Feb 7, 2025 21:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 1,250 | $164.57 | $205,710.00 |
DisclosureSEC source: 0001022079-25-000022 · wk-form4_1738964245.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,867 Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 21:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 72 | $158.04 | $11,378.66 |
DisclosureSEC source: 0001022079-25-000018 · wk-form4_1738359071.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,117 F1 · shares: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| October 21, 2024 Filed Oct 25, 2024 20:27 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 76 | $149.37 | $11,352.20 |
DisclosureSEC source: 0001022079-24-000200 · wk-form4_1729888063.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,045 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| July 22, 2024 Filed Jul 26, 2024 22:30 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 77 | $146.97 | $11,316.92 |
DisclosureSEC source: 0001022079-24-000164 · wk-form4_1722033015.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,969 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| May 23, 2024 Filed May 28, 2024 23:00 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,414 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-065503 · ownership.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,265 F1 · shares: Shares will vest over a 3-year period in equal yearly installments beginning May 23, 2025. Read SEC document |
| May 16, 2024 Filed May 20, 2024 23:19 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,482 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-24-000121 · wk-form4_1716247144.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,892 F1 · shares: Represents an award of restricted share units. Read SEC document |
| April 22, 2024 Filed Apr 26, 2024 21:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 81 | $126.24 | $10,225.76 |
DisclosureSEC source: 0001022079-24-000107 · wk-form4_1714167920.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,410 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| March 04, 2024 Filed Mar 6, 2024 22:28 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | SaleCommon Stock | 2,500 | $85.56 | $213,900.00 |
DisclosureSEC source: 0000950170-24-027348 · ownership.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,851 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.50 to $85.62, inclusive. The reporting personundertakes to provide to Acadia Healthcare Company, Inc. (Acadia), any security holder of Acadia, or the staff of the Securities and Exchange Commission, upon request, fullinformation regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 23, 2024 Filed Feb 23, 2024 21:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | SaleCommon Stock | 2,500 | $126.64 | $316,596.50 |
DisclosureSEC source: 0001022079-24-000052 · wk-form4_1708724051.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,329 Read SEC document |
| January 31, 2024 Filed Feb 2, 2024 21:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 88 | $129.33 | $11,380.78 |
DisclosureSEC source: 0001022079-24-000017 · wk-form4_1706910033.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,829 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| October 23, 2023 Filed Oct 26, 2023 22:18 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 92 | $122.86 | $11,303.40 |
DisclosureSEC source: 0001022079-23-000165 · wk-form4_1698358671.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,741 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the Reporting Person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The Reporting Person has chosen to report such transaction early on this Form 4. Read SEC document |
| July 25, 2023 Filed Jul 27, 2023 20:41 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 78 | $144.59 | $11,278.10 |
DisclosureSEC source: 0001022079-23-000138 · wk-form4_1690490465.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,649 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| May 18, 2023 Filed May 19, 2023 21:05 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,229 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-013386 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,351 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 18, 2024. Read SEC document |
| May 17, 2023 Filed May 19, 2023 22:24 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,369 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-23-000117 · wk-form4_1684535036.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,571 F1 · security: Represents an award of restricted share units. Read SEC document |
| April 24, 2023 Filed Apr 25, 2023 21:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 72 | $143.08 | $10,301.83 |
DisclosureSEC source: 0001022079-23-000083 · wf-form4_168245913854661.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,202 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| February 01, 2023 Filed Feb 3, 2023 21:40 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 64 | $146.75 | $9,391.74 |
DisclosureSEC source: 0001022079-23-000012 · wf-form4_167546039141816.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,130 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| October 19, 2022 Filed Oct 21, 2022 20:34 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 74 | $127.67 | $9,447.36 |
DisclosureSEC source: 0001022079-22-000141 · wf-form4_166638443077977.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,066 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| July 20, 2022 Filed Jul 21, 2022 20:33 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 70 | $134.47 | $9,412.67 |
DisclosureSEC source: 0001022079-22-000121 · wf-form4_165843559733738.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,992 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transaction early on this Form 4. Read SEC document |
| May 19, 2022 Filed May 20, 2022 21:12 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,303 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-019072 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,122 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 19, 2023. Read SEC document |
| May 18, 2022 Filed May 20, 2022 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,292 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-22-000091 · wf-form4_165307863530124.xml · nonDerivative · entry 2 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,922 F3 · security: Represents an award of restricted share units. Read SEC document |
| April 18, 2022 Filed May 20, 2022 20:31 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | OtherCommon Stock | 61 | $134.88 | $8,227.68 |
DisclosureSEC source: 0001022079-22-000091 · wf-form4_165307863530124.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,630 F1 · shares: Reflects shares that were acquired pursuant to a dividend reinvestment plan administered by the reporting person's broker and eligible for deferred reporting on Form 5 under Rule 16a-6. The reporting person has chosen to report such transactions early on this Form 4. F2 · balance_after: The amount includes approximately 169 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrored a dividend reinvestment plan that was sponsored by the registrant through February 2022. Read SEC document |
| May 21, 2021 Filed May 25, 2021 20:39 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,363 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-21-000090 · wf-form4_162197510268433.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,400 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 193 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| May 06, 2021 Filed May 7, 2021 21:05 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 2,550 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-21-018711 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,819 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 6, 2022. Read SEC document |
| May 19, 2020 Filed May 21, 2020 20:35 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,531 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-20-000122 · wf-form4_159009333493069.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,844 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes approximately 149 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. F3 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 07, 2020 Filed May 8, 2020 21:02 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 6,609 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-012425 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,269 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 7, 2021. Read SEC document |
| May 14, 2019 Filed May 16, 2019 20:37 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,722 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-19-000135 · wf-form4_155803901969649.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,125 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. F3 · balance_after: The amount includes approximately 137 shares acquired via dividend reinvestment since the date of the last filing on Form 4 pursuant to a dividend reinvestment plan, sponsored by a broker-dealer, that essentially mirrors a dividend reinvestment plan sponsored by the registrant. Read SEC document |
| May 02, 2019 Filed May 6, 2019 21:35 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 4,943 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-19-012244 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,660 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 2, 2020. Read SEC document |
| May 15, 2018 Filed May 17, 2018 21:09 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,644 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-18-000113 · wf-form4_152659132224957.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,213 F1 · security: Represents an award of restricted share units. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| May 03, 2018 Filed May 4, 2018 21:06 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 4,125 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-18-011540 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,717 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 3, 2019. Read SEC document |
| May 25, 2017 Filed May 26, 2017 21:04 UTC | Acadia Healthcare Company, Inc. ACHC · Entity 4312 | GrantCommon Stock | 3,752 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-17-014579 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,592 F1 · shares: Shares will vest over a 3-year period in equal annual installments beginning May 25, 2018. Read SEC document |
| May 16, 2017 Filed May 18, 2017 20:42 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantCommon Stock | 1,573 | $0.00 | $0.00 |
DisclosureSEC source: 0001022079-17-000134 · wf-form4_149514012947244.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,525 F1 · security: Represents an award of restricted share units granted on May 16, 2017. F2 · balance_after: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:34 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerRestricted Stock Units · Derivative | 3,320 | $43.50 | $144,420.00 |
DisclosureSEC source: 0000899243-17-003207 · doc4.xml · derivative · entry 4 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,320 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · kind: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F3 · price: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F6 · derivative.exercise_date: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date. F6 · derivative.expiration_date: These restricted stock units were to vest one-third on each of the first, second and third anniversaries of the March 3, 2016 grant date. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:34 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerRestricted Stock Units · Derivative | 1,630 | $43.50 | $70,905.00 |
DisclosureSEC source: 0000899243-17-003207 · doc4.xml · derivative · entry 3 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,630 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · kind: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F3 · price: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F5 · derivative.exercise_date: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the May 21, 2015 grant date. F5 · derivative.expiration_date: These restricted stock units were to vest in two equal installments on the second and third anniversaries of the May 21, 2015 grant date. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:34 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerRestricted Stock Units · Derivative | 916 | $43.50 | $39,846.00 |
DisclosureSEC source: 0000899243-17-003207 · doc4.xml · derivative · entry 2 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 916 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents the right to receive, at settlement, one share of common stock. F3 · kind: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F3 · price: Pursuant to the Merger Agreement, immediately prior to the effective time, any vesting conditions applicable to each restricted stock unit ("Stock Unit") automatically accelerated in full, each Stock Unit was cancelled, and the Reporting Person was entitled to receive (without interest) an amount in cash equal to the product of (x) the total number of shares subject to such Stock Unit immediately prior to the effective time multiplied by (y) $43.50. Withholding taxes will be withheld from the proceeds otherwise due to the Reporting Person. F4 · derivative.exercise_date: These restricted stock units were to vest on May 20, 2017. F4 · derivative.expiration_date: These restricted stock units were to vest on May 20, 2017. Read SEC document |
| February 06, 2017 Filed Feb 8, 2017 20:34 UTC | TEAM HEALTH HOLDINGS INC. TMH · Entity 16682 | Disposition to issuerCommon Stock | 6,498 | $43.50 | $282,663.00 |
DisclosureSEC source: 0000899243-17-003207 · doc4.xml · nonDerivative · entry 1 Gregg Vicky B · CIK 0001510304 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable witholding taxes. F1 · price: On February 6, 2017, an affiliate of The Blackstone Group, L.P. acquired the Issuer pursuant to that certain Agreement and Plan of Merger, dated as of October 30, 2016 (the "Merger Agreement"), among the Issuer, Tennessee Merger Sub, Inc., a Delaware corporation ("Merger Sub"), and Tennessee Parent, Inc., a Delaware corporation ("Parent"). Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) was cancelled and automatically converted into the right to receive $43.50 in cash, without interest and subject to applicable witholding taxes. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.